These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 1280377)

  • 1. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
    Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
    Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
    Fukao H; Yamamoto K; Matsuo O
    Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
    Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
    Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].
    Nagaizumi K; Kuroso K; Amano K; Sato T; Fukutake K; Fujimaki M
    Rinsho Byori; 1994 Jul; 42(7):707-12. PubMed ID: 8065036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of accelerated fibrinolysis in hepatosplenic schistosomiasis.
    Omran SA; Madkour BA; Essawy FM; Toima SM; el Kaliouby AH; Shams el Din AA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):819-22. PubMed ID: 1489902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
    Koyama T; Kakishita E; Nakai Y; Okamoto E
    Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogenolysis in thrombotic thrombocytopenic purpura.
    Kakishita E; Koyama T; Higuchi M; Kunitomi O; Oura Y; Nagai K
    Am J Hematol; 1989 Sep; 32(1):14-9. PubMed ID: 2502913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.
    Sakata Y; Murakami T; Noro A; Mori K; Matsuda M
    Blood; 1991 May; 77(9):1949-57. PubMed ID: 1708294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttrauma coagulation and fibrinolysis.
    Gando S; Tedo I; Kubota M
    Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K; Fujimaki M
    Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
    Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
    Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
    van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W
    Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
    Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
    Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an active fibrinolytic system in normal human bone marrow.
    McWilliam NA; Robbie LA; Barelle CJ; Adey G; Prasad S; Bennett B; Booth NA
    Br J Haematol; 1996 Apr; 93(1):170-6. PubMed ID: 8611456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.